Truncated forms of DNA-binding estrogen receptors in human breast cancer.
Open Access
- 1 August 1991
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 88 (2), 700-706
- https://doi.org/10.1172/jci115356
Abstract
The likelihood a breast cancer will respond to antiestrogen therapy depends on the tumor content of immunoreactive or ligand-binding estrogen receptor (ER). To investigate the failure of many ER-positive breast cancers to respond to antiestrogen therapy, we examined by gel-shift assay the ability of tumor ER to bind its cognate estrogen response element (ERE). Analysis of 38 primary breast cancers showed that some tumors containing abundant immunoreactive ER failed to demonstrate DNA binding ER. In many other ER-positive tumors, the fraction of DNA binding ER was low and consisted primarily of truncated receptor forms, which on Western analysis were revealed to be 50 kD homodimers and 67-50 kD ER heterodimers. The use of protease inhibitors during tumor extraction and the demonstration of nuclear-localizing ER and ERE-binding COUP (chicken ovalbumin upstream promoter) protein in these tumors indicated that the truncated forms of ER were likely present in vivo. The presence of intact DNA binding ER correlated with higher tumor content of immunoreactive sex steroid receptors (ER and/or PR), standard predictors of tumor responsiveness to antiestrogen, suggesting that loss or truncation of DNA binding ER may be an important prognostic parameter accounting for some forms of clinical resistance to antiestrogen therapy.Keywords
This publication has 31 references indexed in Scilit:
- A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance.JCI Insight, 1991
- Variant human breast tumor estrogen receptor with constitutive transcriptional activity.1991
- Quantitative imaging of immunocytochemical (pap) estrogen receptor staining patterns in breast cancer sectionsCytometry, 1990
- Endocrine therapy of metastatic breast cancerJournal of Endocrinological Investigation, 1989
- Estradiol-Stimulated Proteolytic Cleavage of the Estrogen Receptor in Mouse UterusEndocrinology, 1988
- The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimerCell, 1988
- Immunochemical studies of estrogen receptorsJournal of Steroid Biochemistry, 1984
- The prognostic role of progesterone receptors in human breast cancer.1983
- Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistanceCell, 1982
- Estradiol receptor analysis in human breast cancer tissue by isoelectric focusing in polyacrylamide gel.1978